Chinese Journal of Ophthalmology and Otorhinolaryngology, Volume. 25, Issue 4, 263(2025)
Research status of medical quality control for age-related cataracts
[1] [1] GBD 2019 Blindness and Vision Impairment Collaborators，Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study[J]. Lancet Glob Health, 2021, 9(2): e144-e160. DOI: 10.1016/s2214-109x(20)30489-7.
[2] [2] SONG P, WANG H, THEODORATOU E, et al. The national and subnational prevalence of cataract and cataract blindness in China: a systematic review and meta-analysis[J]. J Glob Health, 2018, 8(1): 010804. DOI: 10.7189/jogh.08.010804.
[4] [4] MILLER K M, OETTING T A, TWEETEN J P, et al. Cataract in the adult eye preferred practice pattern[J]. Ophthalmology, 2022, 129(1): P1-P126. DOI: 10.1016/j.ophtha.2021.10.006.
[7] [7] LUNDSTRM M, BARRY P, HENRY Y, et al. Evidence-based guidelines for cataract surgery: guidelines based on data in the European registry of quality outcomes for cataract and refractive surgery database[J]. J Cataract Refract Surg, 2012, 38(6): 1086-1093. DOI: 10.1016/j.jcrs.2012.03.006.
[9] [9] RODRGUEZ-CARAVACA G, GARCA-SENZ M C, VILLARDEL-CAMPO M C, et al. Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery[J]. J Cataract Refract Surg, 2013, 39(9): 1399-1403. DOI: 10.1016/j.jcrs.2013.03.031.
[10] [10] SALHA C P, MACHADO L N, SANTOS M S D. Efficacy of prophylactic intracameral antibiotic in preventing endophthalmitis after cataract surgery[J]. Arq Bras Oftalmol, 2024, 88(3): S0004-27492025000300304. DOI: 10.5935/0004-2749.2023-0345.
[11] [11] GARAT M, MOSER C L, ALONSO-TARRS C, et al. Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study[J]. J Cataract Refract Surg, 2005, 31(11): 2230-2234. DOI: 10.1016/j.jcrs.2005.08.053.
[12] [12] ROMERO P, MNDEZ I, SALVAT M, et al. Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery[J]. J Cataract Refract Surg, 2006, 32(3): 438-441. DOI: 10.1016/j.jcrs.2005.12.135.
[13] [13] HERRINTON L J, SHORSTEIN N H, PASCHAL J F, et al. Comparative effectiveness of antibiotic prophylaxis in cataract surgery[J]. Ophthalmology, 2016, 123(2): 287-294. DOI: 10.1016/j.ophtha.2015.08.039.
[14] [14] BHATTA S, PANT N, POUDEL M. Postoperative endophthalmitis with and without intracameral moxifloxacin prophylaxis in a high volume surgery setting[J]. BMJ Open Ophthalmol, 2021, 6(1): e000609. DOI: 10.1136/bmjophth-2020-000609.
[15] [15] SUN J, GUO Z, LI H, et al. Acute infectious endophthalmitis after cataract surgery: epidemiological characteristics, risk factors and incidence trends, 2008-2019[J]. Infect Drug Resist, 2021, 14: 1231-1238. DOI: 10.2147/idr.s304675.
[16] [16] YAO K, ZHU Y, ZHU Z, et al. The incidence of postoperative endophthalmitis after cataract surgery in China: a multicenter investigation of 2006-2011[J]. Br J Ophthalmol, 2013, 97(10): 1312-1317. DOI: 10.1136/bjophthalmol-2013-303282.
[17] [17] ZHANG X, CHEN Z, LI X, et al. Management and prognosis of acute post-cataract surgery endophthalmitis: a 10-year retrospective analysis in Eastern China[J]. Antibiotics (Basel), 2023, 12(12): 1670. DOI: 10.3390/antibiotics12121670.
[18] [18] FRILING E, BRO T, LUNDSTRM M, et al. Endophthalmitis after cataract surgery and effect of different intracameral antibiotic regimes in Sweden 2011-2017: national registry study[J]. J Cataract Refract Surg, 2024, 50(8): 828-835. DOI: 10.1097/j.jcrs.0000000000001464.
[19] [19] SCHMIER J K, HULME-LOWE C K, COVERT D W, et al. An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010-2014[J]. Clin Ophthalmol, 2016, 10: 2121-2127. DOI: 10.2147/opth.s117958.
[20] [20] FRILING E, LUNDSTRM M, STENEVI U, et al. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study[J]. J Cataract Refract Surg, 2013, 39(1): 15-21. DOI: 10.1016/j.jcrs.2012.10.037.
[21] [21] CHIQUET C, BOISSET S, PECHINOT A, et al. Massilia timonae as cause of chronic endophthalmitis following cataract surgery[J]. J Cataract Refract Surg, 2015, 41(8): 1778-1780. DOI: 10.1016/j.jcrs.2015.07.016.
[22] [22] MATSUURA K, MIYOSHI T, SUTO C, et al. Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan[J]. J Cataract Refract Surg, 2013, 39(11): 1702-1706. DOI: 10.1016/j.jcrs.2013.05.036.
[23] [23] HAGE A, BASTELICA P, MAJOULET A, et al. Changes in rates of endophthalmitis after cataract surgery over the last 23 years[J]. J Franais D'ophtalmologie, 2025, 48(2): 104385. DOI: 10.1016/j.jfo.2024.104385.
[24] [24] ZHU Y, CHEN X, CHEN P, et al. The occurrence rate of acute-onset postoperative endophthalmitis after cataract surgery in Chinese small- and medium-scale departments of ophthalmology[J]. Sci Rep, 2017, 7: 40776. DOI: 10.1038/srep40776.
[25] [25] ICOZ M, GURTURK ICOZ S G. Importance of optical coherence tomography before cataract surgery[J]. BMC Ophthalmol, 2024, 24(1): 339. DOI: 10.1186/s12886-024-03622-3.
[26] [26] OSHIKA T. Artificial intelligence applications in ophthalmology[J]. Jma J, 2025, 8(1): 66-75. DOI: 10.31662/jmaj.2024-0139.
Get Citation
Copy Citation Text
XU Jie, ZHAO Zhennan, FAN Jing, CHU Ruilin, WEN Wen, YAN Hong, JIANG Yongxiang. Research status of medical quality control for age-related cataracts[J]. Chinese Journal of Ophthalmology and Otorhinolaryngology, 2025, 25(4): 263
Special Issue:
Received: Apr. 21, 2025
Accepted: Aug. 25, 2025
Published Online: Aug. 25, 2025
The Author Email: JIANG Yongxiang (yongxiang_jiang@163.com)
